Treatment | n | S4/S2 ratio | |
---|---|---|---|
[3H]noradrenaline | Vasoconstriction | ||
Control | 7 | 1.08 ± 0.05 | 1.04 ± 0.06 |
DNIC-cysteine 3 μM | 6 | 1.31 ± 0.06** | 0.25 ± 0.02** |
DNIC-thiosulfate 3 μM | 6 | 1.38 ± 0.07** | 0.33 ± 0.04** |
Fe(II)-thiosulfate 10 μM | 6 | 1.01 ± 0.03 | 0.92 ± 0.05 |
SNP 10 μM | 7 | 1.04 ± 0.04 | 0.27 ± 0.06** |
Cys-NO 10 μM | 7 | 1.08 ± 0.06 | 0.23 ± 0.02** |
GS-NO 10 μM | 7 | 1.01 ± 0.03 | 0.27 ± 0.02** |